Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bluebird Bio, Inc. (BLUE) since 2013 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bluebird Bio, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1293971.
Total stock buying since 2013: $900,936.
Total stock sales since 2013: $302,744,213.
Total stock option exercises since 2013: $18,164,530.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 2,674 | $13,092 | 0 | $0 |
| 2024 | 0 | $0 | 53,225 | $32,951 | 0 | $0 |
| 2023 | 0 | $0 | 29,657 | $107,873 | 0 | $0 |
| 2022 | 0 | $0 | 60,375 | $389,963 | 0 | $0 |
| 2021 | 0 | $0 | 32,047 | $1,316,414 | 203,355 | $1,118,452 |
| 2020 | 0 | $0 | 29,953 | $2,487,840 | 600 | $30,306 |
| 2019 | 0 | $0 | 113,356 | $14,484,676 | 89,426 | $3,023,134 |
| 2018 | 0 | $0 | 253,653 | $43,940,267 | 217,526 | $4,893,932 |
| 2017 | 0 | $0 | 568,271 | $74,844,245 | 360,998 | $4,314,958 |
| 2016 | 0 | $0 | 16,898 | $789,291 | 30,986 | $183,782 |
| 2015 | 9,682 | $501,062 | 637,702 | $85,151,065 | 707,734 | $3,728,126 |
| 2014 | 6,469 | $399,874 | 2,827,352 | $78,463,786 | 431,284 | $819,211 |
| 2013 | 0 | $0 | 35,000 | $722,750 | 35,000 | $52,629 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-09-05 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 600 | 50.51 | 30,306 |
| 2019-08-20 | Walsh Jeffrey T. (Chief Strategy Officer) | Sale | 500 | 124.00 | 62,000 |
| 2019-08-20 | Walsh Jeffrey T. (Chief Strategy Officer) | Option Ex | 500 | 24.47 | 12,235 |
| 2019-08-08 | Gregory Philip D (Chief Scientific Officer) | Sale | 950 | 124.03 | 117,823 |
| 2019-08-08 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 700 | 75.60 | 52,919 |
| 2019-08-06 | Davidson David (Chief Medical Officer) | Sale | 5,060 | 116.89 | 591,473 |
| 2019-08-06 | Davidson David (Chief Medical Officer) | Option Ex | 5,060 | 50.51 | 255,580 |
| 2019-08-05 | Gregory Philip D (Chief Scientific Officer) | Sale | 850 | 117.40 | 99,789 |
| 2019-08-05 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 600 | 50.51 | 30,306 |
| 2019-07-05 | Davidson David (Chief Medical Officer) | Sale | 7,660 | 129.85 | 994,666 |
| 2019-07-05 | Davidson David (Chief Medical Officer) | Option Ex | 7,660 | 28.00 | 214,518 |
| 2019-07-05 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,800 | 130.15 | 234,270 |
| 2019-07-05 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,300 | 63.05 | 81,971 |
| 2019-06-18 | Walsh Jeffrey T. (Chief Strategy Officer) | Sale | 100 | 126.12 | 12,612 |
| 2019-06-18 | Walsh Jeffrey T. (Chief Strategy Officer) | Option Ex | 100 | 24.47 | 2,447 |
| 2019-06-10 | Walsh Jeffrey T. (Chief Strategy Officer) | Sale | 1,400 | 126.08 | 176,505 |
| 2019-06-10 | Walsh Jeffrey T. (Chief Strategy Officer) | Option Ex | 1,400 | 24.47 | 34,258 |
| 2019-06-06 | Davidson David (Chief Medical Officer) | Sale | 5,060 | 122.78 | 621,271 |
| 2019-06-06 | Davidson David (Chief Medical Officer) | Option Ex | 5,060 | 50.51 | 255,580 |
| 2019-06-05 | Wentworth Kory James (Principal Accounting Officer) | Sale | 61 | 128.48 | 7,837 |
| 2019-06-05 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,800 | 129.29 | 232,729 |
| 2019-06-05 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,300 | 63.05 | 81,971 |
| 2019-05-10 | Walsh Jeffrey T. (Chief Strategy Officer) | Sale | 1,500 | 132.19 | 198,280 |
| 2019-05-10 | Walsh Jeffrey T. (Chief Strategy Officer) | Option Ex | 1,500 | 24.47 | 36,705 |
| 2019-05-10 | Cole Jason (Chief Operating and) | Option Ex | 562 | 50.51 | 28,386 |
| 2019-05-06 | Davidson David (Chief Medical Officer) | Sale | 6,360 | 139.17 | 885,114 |
| 2019-05-06 | Davidson David (Chief Medical Officer) | Option Ex | 6,360 | 5.50 | 34,980 |
| 2019-05-06 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,800 | 138.56 | 249,406 |
| 2019-05-06 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,300 | 63.05 | 81,971 |
| 2019-04-10 | Walsh Jeffrey T. (Chief Strategy Officer) | Sale | 1,500 | 156.83 | 235,251 |
| 2019-04-10 | Walsh Jeffrey T. (Chief Strategy Officer) | Option Ex | 1,500 | 24.47 | 36,705 |
| 2019-04-05 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,800 | 157.72 | 283,894 |
| 2019-04-05 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,300 | 63.05 | 81,971 |
| 2019-04-04 | Davidson David (Chief Medical Officer) | Sale | 6,360 | 160.28 | 1,019,361 |
| 2019-04-04 | Davidson David (Chief Medical Officer) | Option Ex | 6,360 | 5.50 | 34,980 |
| 2019-03-13 | Davidson David (Chief Medical Officer) | Sale | 3,101 | 146.45 | 454,153 |
| 2019-03-13 | Davidson David (Chief Medical Officer) | Option Ex | 3,101 | 5.50 | 17,055 |
| 2019-03-11 | Walsh Jeffrey T. (Chief Strategy Officer) | Sale | 1,500 | 139.80 | 209,698 |
| 2019-03-11 | Walsh Jeffrey T. (Chief Strategy Officer) | Option Ex | 1,500 | 24.47 | 36,705 |
| 2019-03-05 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,800 | 147.78 | 265,998 |
| 2019-03-05 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,300 | 63.05 | 81,971 |
| 2019-03-04 | Davidson David (Chief Medical Officer) | Sale | 4,910 | 156.41 | 767,948 |
| 2019-03-04 | Davidson David (Chief Medical Officer) | Option Ex | 4,910 | 50.51 | 248,004 |
| 2019-02-28 | Wentworth Kory James (Principal Accounting Officer) | Sale | 51 | 151.71 | 7,737 |
| 2019-02-25 | Wentworth Kory James (Principal Accounting Officer) | Sale | 208 | 150.00 | 31,200 |
| 2019-02-25 | Cole Jason (Chief Operating and) | Sale | 6,248 | 150.77 | 942,023 |
| 2019-02-25 | Cole Jason (Chief Operating and) | Option Ex | 6,248 | 36.52 | 228,176 |
| 2019-02-08 | Walsh Jeffrey T. (Chief Financial and) | Sale | 1,500 | 131.43 | 197,145 |
| 2019-02-08 | Walsh Jeffrey T. (Chief Financial and) | Option Ex | 1,500 | 24.47 | 36,705 |
| 2019-02-05 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,800 | 137.89 | 248,209 |
| 2019-02-05 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,300 | 63.05 | 81,971 |
| 2019-02-04 | Davidson David (Chief Medical Officer) | Sale | 4,910 | 134.15 | 658,676 |
| 2019-02-04 | Davidson David (Chief Medical Officer) | Option Ex | 4,910 | 37.49 | 184,075 |
| 2019-01-28 | Wentworth Kory James (Principal Accounting Officer) | Sale | 209 | 125.96 | 26,326 |
| 2019-01-18 | Davidson David (Chief Medical Officer) | Sale | 2,035 | 130.05 | 264,643 |
| 2019-01-18 | Davidson David (Chief Medical Officer) | Option Ex | 2,035 | 24.47 | 49,796 |
| 2019-01-16 | Walsh Jeffrey T. (Chief Financial) | Sale | 3,000 | 125.14 | 375,429 |
| 2019-01-16 | Walsh Jeffrey T. (Chief Financial) | Option Ex | 3,000 | 24.47 | 73,410 |
| 2019-01-16 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,900 | 124.25 | 236,069 |
| 2019-01-16 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,400 | 75.60 | 105,839 |
| 2019-01-07 | Finger Alison Cecily (Chief Commercial Officer) | Sale | 643 | 113.80 | 73,171 |
| 2019-01-07 | Davidson David (Chief Medical Officer) | Sale | 2,664 | 113.80 | 303,157 |
| 2019-01-07 | Leschly Nick (President and CEO) | Sale | 7,374 | 113.80 | 839,146 |
| 2019-01-07 | Walsh Jeffrey T. (Chief Financial) | Sale | 3,012 | 113.80 | 342,756 |
| 2019-01-07 | Cole Jason (Chief Legal Officer) | Sale | 1,416 | 113.80 | 161,137 |
| 2019-01-07 | Gregory Philip D (Chief Scientific Officer) | Sale | 3,879 | 110.84 | 429,936 |
| 2019-01-07 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 600 | 50.51 | 30,306 |
| 2019-01-03 | Finger Alison Cecily (Chief Commercial Officer) | Sale | 428 | 99.30 | 42,501 |
| 2019-01-03 | Davidson David (Chief Medical Officer) | Sale | 100 | 100.32 | 10,032 |
| 2019-01-03 | Davidson David (Chief Medical Officer) | Option Ex | 100 | 24.47 | 2,447 |
| 2019-01-02 | Davidson David (Chief Medical Officer) | Sale | 7,500 | 97.83 | 733,710 |
| 2019-01-02 | Davidson David (Chief Medical Officer) | Option Ex | 7,500 | 14.98 | 112,387 |
| 2018-12-19 | Wentworth Kory James (Principal Accounting Officer) | Sale | 388 | 103.05 | 39,983 |
| 2018-12-06 | High Susanna Gatti (Chief Operating Officer) | Sale | 1,875 | 105.65 | 198,093 |
| 2018-12-06 | Gregory Philip D (Chief Scientific Officer) | Sale | 850 | 107.07 | 91,006 |
| 2018-12-06 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 600 | 50.51 | 30,306 |
| 2018-12-04 | Davidson David (Chief Medical Officer) | Sale | 2,000 | 120.96 | 241,916 |
| 2018-12-04 | Davidson David (Chief Medical Officer) | Option Ex | 2,000 | 5.50 | 11,000 |
| 2018-12-03 | High Susanna Gatti (Chief Operating Officer) | Sale | 1,890 | 113.83 | 215,134 |
| 2018-12-03 | Davidson David (Chief Medical Officer) | Sale | 6,000 | 113.59 | 681,540 |
| 2018-12-03 | Davidson David (Chief Medical Officer) | Option Ex | 6,000 | 5.50 | 33,000 |
| 2018-11-05 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,800 | 137.49 | 247,476 |
| 2018-11-05 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,300 | 63.05 | 81,971 |
| 2018-11-02 | Davidson David (Chief Medical Officer) | Sale | 5,000 | 132.06 | 660,320 |
| 2018-11-02 | Davidson David (Chief Medical Officer) | Option Ex | 5,000 | 5.50 | 27,500 |
| 2018-10-10 | Walsh Jeffrey T. (Chief Financial) | Sale | 1,500 | 135.83 | 203,739 |
| 2018-10-10 | Walsh Jeffrey T. (Chief Financial) | Option Ex | 1,500 | 24.47 | 36,705 |
| 2018-10-05 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,800 | 140.30 | 252,543 |
| 2018-10-05 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,300 | 63.05 | 81,971 |
| 2018-10-02 | Davidson David (Chief Medical Officer) | Sale | 5,000 | 139.60 | 698,020 |
| 2018-10-02 | Davidson David (Chief Medical Officer) | Option Ex | 5,000 | 5.50 | 27,500 |
| 2018-09-10 | Mandell James (Director) | Sale | 1,000 | 151.09 | 151,093 |
| 2018-09-10 | Walsh Jeffrey T. (Chief Financial) | Sale | 1,500 | 150.34 | 225,511 |
| 2018-09-10 | Walsh Jeffrey T. (Chief Financial) | Option Ex | 1,500 | 24.47 | 36,705 |
| 2018-09-05 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,800 | 164.06 | 295,304 |
| 2018-09-05 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,300 | 63.05 | 81,971 |
| 2018-09-04 | Davidson David (Chief Medical Officer) | Sale | 7,000 | 166.89 | 1,168,258 |
| 2018-09-04 | Davidson David (Chief Medical Officer) | Option Ex | 7,000 | 5.50 | 38,500 |
| 2018-08-30 | Walsh Jeffrey T. (Chief Financial) | Sale | 20,000 | 175.70 | 3,513,920 |
| 2018-08-30 | Walsh Jeffrey T. (Chief Financial) | Option Ex | 20,000 | 10.69 | 213,720 |
| 2018-08-20 | Finger Alison Cecily (Chief Commercial Officer) | Sale | 259 | 158.07 | 40,941 |
| 2018-08-10 | Walsh Jeffrey T. (Chief Financial) | Sale | 1,500 | 157.12 | 235,672 |
| 2018-08-10 | Walsh Jeffrey T. (Chief Financial) | Option Ex | 1,500 | 5.50 | 8,250 |
| 2018-08-08 | Cole Jason (Chief Legal Officer) | Option Ex | 4,438 | 22.53 | 99,988 |
| 2018-08-06 | Gregory Philip D (Chief Scientific Officer) | Sale | 1,800 | 156.91 | 282,432 |
| 2018-08-06 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,300 | 63.05 | 81,971 |
| 2018-08-02 | Davidson David (Chief Medical Officer) | Sale | 7,000 | 151.16 | 1,058,148 |
| 2018-08-02 | Davidson David (Chief Medical Officer) | Option Ex | 7,000 | 5.50 | 38,500 |
| 2018-08-02 | Walsh Jeffrey T. (Chief Financial) | Sale | 21,500 | 152.96 | 3,288,640 |
| 2018-08-02 | Walsh Jeffrey T. (Chief Financial) | Option Ex | 21,500 | 5.50 | 118,250 |
| 2018-07-11 | Davidson David (Chief Medical Officer) | Sale | 3,000 | 180.15 | 540,444 |
| 2018-07-11 | Davidson David (Chief Medical Officer) | Option Ex | 3,000 | 5.50 | 16,500 |
| 2018-07-09 | Cole Jason (Chief Legal Officer) | Sale | 5,126 | 170.61 | 874,551 |
| 2018-06-18 | Gregory Philip D (Chief Scientific Officer) | Sale | 3,901 | 178.10 | 694,775 |
| 2018-06-14 | Vachon Mark (Director) | Sale | 1,000 | 190.10 | 190,104 |
| 2018-06-04 | High Susanna Gatti (Chief Operating Officer) | Sale | 3,500 | 199.11 | 696,892 |
| 2018-06-04 | High Susanna Gatti (Chief Operating Officer) | Option Ex | 3,500 | 68.65 | 240,275 |
| 2018-06-04 | Vachon Mark (Director) | Sale | 6,000 | 189.17 | 1,135,038 |
| 2018-06-04 | Vachon Mark (Director) | Option Ex | 6,000 | 39.17 | 235,020 |
| 2018-06-04 | Davidson David (Chief Medical Officer) | Sale | 13,000 | 189.04 | 2,457,481 |
| 2018-06-04 | Davidson David (Chief Medical Officer) | Option Ex | 13,000 | 24.47 | 318,110 |
| 2018-05-04 | Cole Jason (Chief Legal Officer) | Sale | 3,750 | 170.23 | 638,366 |
| 2018-05-02 | Davidson David (Chief Medical Officer) | Sale | 13,000 | 177.04 | 2,301,481 |
| 2018-05-02 | Davidson David (Chief Medical Officer) | Option Ex | 13,000 | 24.47 | 318,110 |
| 2018-04-12 | Davidson David (Chief Medical Officer) | Sale | 3,000 | 180.17 | 540,507 |
| 2018-04-12 | Davidson David (Chief Medical Officer) | Option Ex | 3,000 | 24.47 | 73,410 |
| 2018-04-02 | Davidson David (Chief Medical Officer) | Sale | 22,000 | 167.11 | 3,676,508 |
| 2018-04-02 | Davidson David (Chief Medical Officer) | Option Ex | 22,000 | 24.47 | 538,340 |
| 2018-04-02 | Gregory Philip D (Chief Scientific Officer) | Sale | 2,250 | 169.05 | 380,369 |
| 2018-04-02 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,250 | 50.51 | 63,137 |
| 2018-03-15 | Vachon Mark (Director) | Sale | 6,000 | 215.07 | 1,290,408 |
| 2018-03-15 | Vachon Mark (Director) | Option Ex | 6,000 | 30.47 | 182,820 |
| 2018-03-02 | Davidson David (Chief Medical Officer) | Sale | 4,000 | 201.53 | 806,128 |
| 2018-03-02 | Davidson David (Chief Medical Officer) | Option Ex | 4,000 | 5.50 | 22,000 |
| 2018-02-28 | High Susanna Gatti (Chief Operating Officer) | Sale | 1,044 | 202.57 | 211,478 |
| 2018-02-28 | High Susanna Gatti (Chief Operating Officer) | Option Ex | 1,044 | 68.65 | 71,670 |
| 2018-02-02 | Davidson David (Chief Medical Officer) | Sale | 4,000 | 202.56 | 810,220 |
| 2018-02-02 | Davidson David (Chief Medical Officer) | Option Ex | 4,000 | 5.50 | 22,000 |
| 2018-02-01 | Gregory Philip D (Chief Scientific Officer) | Sale | 2,250 | 204.40 | 459,904 |
| 2018-02-01 | Gregory Philip D (Chief Scientific Officer) | Option Ex | 1,250 | 50.51 | 63,137 |
| 2018-01-30 | High Susanna Gatti (Chief Operating Officer) | Sale | 17,262 | 198.11 | 3,419,792 |
| 2018-01-30 | High Susanna Gatti (Chief Operating Officer) | Option Ex | 14,794 | 68.65 | 1,015,608 |
| 2018-01-30 | Cole Jason (Chief Legal Officer) | Sale | 25,000 | 198.11 | 4,952,750 |
| 2018-01-30 | Cole Jason (Chief Legal Officer) | Option Ex | 25,000 | 22.53 | 563,250 |
| 2018-01-08 | Davidson David (Chief Medical Officer) | Sale | 1,200 | 173.01 | 207,609 |
| 2018-01-08 | Davidson David (Chief Medical Officer) | Option Ex | 1,200 | 5.50 | 6,600 |
| 2018-01-05 | Davidson David (Chief Medical Officer) | Sale | 2,322 | 173.71 | 403,361 |
| 2018-01-05 | Leschly Nick (President and CEO) | Sale | 5,435 | 173.71 | 944,130 |
| 2018-01-05 | Walsh Jeffrey T. (Chief Financial) | Sale | 3,060 | 173.71 | 531,561 |
| 2018-01-05 | Cole Jason (Chief Legal Officer) | Sale | 1,129 | 173.72 | 196,124 |
Insider trading activities including stock purchases, stock sales, and option exercises of BLUE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bluebird Bio, Inc. (symbol BLUE, CIK number 1293971) see the Securities and Exchange Commission (SEC) website.